Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103553941B reveals a novel chiral catalyst route for Levalbuterol, offering high purity and significant supply chain cost reduction advantages.
Patent CN106674121A details high-yield 4-halogen-1H-imidazole preparation. Reduces waste and cost for pharmaceutical intermediates supply chains globally.
Patent CN112176019B details a high-yield biocatalytic route for (R)-1-(3-trifluoromethylphenyl) ethanol using recombinant E. coli and deep eutectic solvents, ensuring >99.9% e.e. and scalable production for neuroprotective intermediates.
Patent CN116606259B reveals a high-yield three-step route for Sha Mizhu intermediates. This method reduces pollution and enhances supply chain stability for veterinary drug manufacturers.
Patent CN115109041B offers high-yield 3CL inhibitor route. Reduces cost and enhances supply chain reliability for global pharmaceutical procurement teams.
Novel preparation method for Somalutide side chain intermediates using orthogonal protection. Enhances purity and scalability for peptide manufacturing.
Discover the advanced synthesis of N-[3-nitro-4-methyl-phenyl]-4-aldehyde-benzamide via patent CN101654416B. A cost-effective route for kinase inhibitor intermediates ensuring supply chain stability.
Patent CN115109041B reveals high-yield synthesis route for 3CL inhibitor intermediates. Offers significant cost reduction and scalable manufacturing for global supply chains.
Patent CN102030648B details a novel asymmetric dihydroxylation route for high-purity chiral intermediates, offering scalable manufacturing and cost efficiency for cardiovascular drug production.
Patent CN102206170A details a mild, one-pot synthesis of Agomelatine using Nickel Chloride, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN102924480B reveals a novel mixed anhydride route for D(-)-sulbenicillin sodium, offering improved solubility and yield for cost reduction in API manufacturing.
Patent CN114950452A reveals a novel Co-Y-Ce catalyst for high-purity L-2-aminopropanol synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN106432195B reveals a streamlined route for (R)-2-(2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide, enhancing purity and reducing costs.
Patent CN110684066A reveals a greener T3P-mediated route for Citicoline Sodium, eliminating benzene and phosgene while ensuring >99% purity for reliable API intermediate supply.
Patent CN103508908A details a green nitrosation-hydrogenation route for high-purity 4-amino-3-methylphenol, offering significant cost reduction and supply chain reliability for global buyers.
Patent CN110240551B reveals a high-yield catalytic route for Fmoc-beta-Ala-Gly-OH, offering superior purity and cost efficiency for peptide manufacturing.
Metal-free synthesis of alpha-chloroketones from styrenes. Safe, high purity, scalable process for pharmaceutical intermediates manufacturing.
Novel silylation-bromination route for high-purity CBD. Stable intermediates ensure supply chain continuity and cost reduction in cannabinoid manufacturing.
Novel Ni-catalyzed route for chiral nafoxidine-3-carboxylic acid. Enhances purity and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN102863493B reveals a high-yield beta-thymidine method avoiding corrosive reagents, offering cost reduction and supply reliability for pharmaceutical manufacturers.